A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy

A key factor in dendritic cell (DC)-based tumor immunotherapy is the identification of an immunoadjuvant capable of inducing DC maturation to enhance cellular immunity. The efficacy of a 50S ribosomal protein L7/L12 (rplL) from Mycobacterium tuberculosis Rv0652, as an immunoadjuvant for DC-based tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Jun, Shin, Sung Jae, Lee, Moon Hee, Lee, Min-Goo, Kang, Tae Heung, Park, Won Sun, Soh, Byoung Yul, Park, Jung Hee, Shin, Yong Kyoo, Kim, Han Wool, Yun, Cheol-Heui, Jung, In Duk, Park, Yeong-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125215/
https://www.ncbi.nlm.nih.gov/pubmed/25102137
http://dx.doi.org/10.1371/journal.pone.0104351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125215/
https://www.ncbi.nlm.nih.gov/pubmed/25102137
http://dx.doi.org/10.1371/journal.pone.0104351

Ejemplares similares